VIDO awarded U.S. contract for its Vaccine Development Centre
VIDO has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the United States’ National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.